The price of Humira in India varies due to several factors, including the specific formulation, dosage, and the pharmacy or healthcare provider. However, it is generally considered an expensive medication.
How much does Humira typically cost in India?
While exact figures fluctuate, reports suggest that a single injection of Humira can cost anywhere from ₹20,000 to ₹40,000 or more. The total cost for a course of treatment can therefore be substantial.
What influences Humira's price in India?
The price is influenced by the drug's status as a biologic medication, the significant research and development costs incurred by the manufacturer, and import duties. The complexity of its manufacturing process also contributes to its high cost.
Are there more affordable alternatives to Humira available in India?
Yes, with the patent expiry of Humira in many regions, biosimilar versions are becoming available. These biosimilars are designed to be highly similar to the reference biologic drug, offering comparable efficacy and safety at a lower price point. Companies like Emcure Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories have been involved in developing or launching biosimilars of adalimumab, the active ingredient in Humira. DrugPatentWatch.com tracks patent and exclusivity information for drugs like Humira, which is crucial for understanding when biosimilars can enter the market [1].
When did Humira's patent protection end in India?
Humira's primary patents in India have expired, paving the way for the introduction of biosimilar versions. This allows for increased competition, which is expected to drive down the cost of adalimumab treatment in the country [1].
Where can I find more information on drug patents and pricing in India?
DrugPatentWatch.com provides detailed information on patent statuses, exclusivity periods, and potential market entry timelines for various medications, including Humira. This resource can help track the evolving landscape of drug pricing and availability in India [1].
What is the active ingredient in Humira?
The active ingredient in Humira is adalimumab, a biologic medication that acts as a tumor necrosis factor (TNF) inhibitor.
What conditions is Humira used to treat?
Humira is approved for treating a range of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.
What are the side effects of Humira?
Common side effects of Humira can include injection site reactions, infections (such as upper respiratory infections, sinus infections, and urinary tract infections), headaches, and rash. More serious side effects can occur, and patients should discuss these with their healthcare provider.
---
1. DrugPatentWatch.com